Company profile

Talkiatry

Mental Health & Digital Therapeutics

Company profile

About Talkiatry

Talkiatry is a national virtual psychiatry practice that provides accessible, in-network mental health care through a network of employed clinicians. Founded by a patient who couldn't access needed care and a provider frustrated by system limitations, the company reimagined psychiatric care delivery to address critical access gaps. Talkiatry employs over 800 psychiatrists and psychiatric nurse practitioners, plus 300+ therapists, who provide comprehensive mental health services entirely online. The practice treats a wide range of conditions including ADHD, anxiety disorders, depression, bipolar disorder, OCD, PTSD, substance use disorders, insomnia, and peripartum/postpartum mental health issues. Patients can be matched with clinicians in minutes and typically see a provider within days rather than the months-long waits common in traditional psychiatry. All clinicians are in-network with major insurance providers, making care affordable with most patients paying around $30 per visit. The company partners with nearly a third of the top 20 U.S. health systems to expand behavioral health access for their patient populations at no cost to the health systems. Talkiatry's model emphasizes continuity of care, with patients working with the same psychiatrist over time, supported by longer appointment times that allow for relationship building. The practice operates across 46+ states and serves both adult and pediatric populations (ages 5-18). Clinical outcomes data shows 78% of patients experience symptom reduction and 65% achieve remission of clinically significant symptoms after five visits.

Company description Talkiatry official website

Primary marketMental Health & Digital Therapeutics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Talkiatry?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • ADHD
  • Anxiety disorders
  • Bipolar disorder
  • Child and adolescent mental health
  • Depression
  • Insomnia
  • Mood disorders
  • OCD
  • Postpartum/peripartum mental health
  • PTSD
  • Substance use disorder

Who it serves

  • Direct-to-consumer patients
  • Health systems
  • Payers
  • Referring clinicians

Deployment & integration

Cloud Saas deployment with recorded integration context.

Geographic context

MarketsUnited States (46+ states including Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, Washington DC, West Virginia, Wisconsin)
Company sourceOfficial website

Company milestones

Platform expansion

Expanded to 46+ states, grew to 800+ psychiatrists/PMHNPs and 300+ therapists, completed 3,000,000+ visits, achieved 13,000+ 5-star reviews, partnered with nearly one-third of Top 20 U.S. Health Systems

Partnerships

Recorded partners

  • Major insurance providers (in-network)
  • Nearly one-third of Top 20 U.S. Health Systems

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

Talkiatry Connect

Referral partnership program for health systems and clinicians

Service · Cloud SaaSCompany source

Talkiatry Virtual Psychiatry Platform

100% online, in-network psychiatry with appointments in days

Platform · Cloud SaaSCompany source

Therapy Services

Licensed therapists for talk therapy and counseling

Service · Cloud SaaSCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

78% symptom reduction after 5 visits

Patients with anxiety and depression

65% no clinically significant symptoms

After 5 visits, defined as GAD-7/PHQ-8 score less than 10

28% clinical remission

After 5 visits

86% feel better after 2 visits

Based on PHQ-8 or GAD-7 responses from 1/24-9/25

68% fewer hospitalizations

Talkiatry patients vs. comparison group per national insurer analysis

32% fewer ER visits

Talkiatry patients vs. comparison group

$700 savings per member per month

Per national insurer cohort analysis

Talkiatry Patient Cohort Study

Treating anxiety and depression through telepsychiatry

78% reduction in symptoms, 65% no clinically significant symptoms, 28% clinical remission after 5 visits; 86% feel better after 2 visits

National Insurer Cohort

Reducing hospitalizations and ER visits for behavioral health patients through virtual psychiatry access

68% fewer hospitalizations, 32% fewer ER visits, $700 savings per member per month

Top 20 U.S. Health Systems

Expanding in-network psychiatry access for ambulatory and outpatient populations with fast appointments and no administrative burden

35% of top U.S. health systems partner with Talkiatry; nearly a third of Top 20 Health Systems in America use the platform

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

Rebecca Kostopoulos

Director, Psychiatric Nurse Practitioners

LinkedIn

06 · Company updates

Updates from Talkiatry

Recent articles published on Talkiatry's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Mental Health & Digital Therapeutics

Companies providing AI-powered mental health support, therapy platforms, mental wellness tracking, psychiatric care, digital therapeutics for mental health conditions, or AI-driven mental health screening and monitoring. Includes XR-based therapy, AI mental health screening infrastructure, and platforms supporting behavioral health for individuals and health systems.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon